Clinical trial

Treatment With Erythropoietin and Cognition During Hypoglycaemia

NCT00615368

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-05-01

PhaseNA

Study timeline

Study start (unknown)2008-05-01Date precision: month

Registry last updated2015-08-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesunresolved

Hypoglycemiaunresolved

Interventions

Epoetin alfaDRUG · verified · RxNorm: epoetin alfa

Isotonic NaCl (Placebo)DRUG

Sponsors & collaborators

Hillerod Hospital, Denmarklead sponsor

Maastricht University Medical Centercollaborator

Copenhagen University Hospital, Rigshospitaletcollaborator

Steno Diabetes Center Copenhagencollaborator

Erasmus Medical Centercollaborator

Aarhus University Hospitalcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00615368 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.